Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Market watchers are anticipating strong growth driven by the robust sales of Lilly's blockbuster treatments, particularly recent launches. However, there are also concerns about potential headwinds from generic c